UBS fined $125mn over lax money laundering controls

Swiss bank failed to implement adequate curbs despite previous sanction by US regulators

Related

More Finance

FinanceOriginal

AstraZeneca investors raise concerns over mega-merger talks

Anchor News-1h ago

FinanceOriginal

Palantir forecasts greater demand from US groups for its AI software

Anchor News-1h ago

FinanceOriginal

An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it ‘odd’

Anchor News-2h ago

FinanceOriginal

This indicator is giving the bull market another lease on life

Anchor News-2h ago